Drug & intervention

perindopril

RxCUI 54552

Clinical trials14
Recruiting0
Related conditions15
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Perindopril

Perindopril is a medication used to treat high blood pressure, heart failure, or stable coronary artery disease. As a long-acting ACE inhibitor, perindopril works by inhibiting production of the vasoconstriction hormone, angiotensin, thereby relaxing blood vessels, increasing urine output, and decreasing blood volume, leading to a reduction of blood pressure. It also increases blood renin activity and decreases aldosterone secretion, causing increased urine production and excretion of sodium. As a prodrug, perindopril is hydrolyzed in the liver to its active metabolite, perindoprilat. It was patented in 1980 and approved for medical use in 1988. Perindopril is taken in the form of perindopril arginine/amlodipine or perindopril erbumine. Both forms are therapeutically equivalent and interchangeable. The combination drug of perindopril, amlodipine, and indapamide is on the World Health Organization's List of Essential Medicines. Perindopril should not be used during pregnancy, as it may harm the fetus. Some people may have allergic reactions to perindopril, while common side-effects may include cough, headache, dizziness, diarrhea, or upset stomach. In Australia during 2023-24, it was the fourth-most prescribed drug.

Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

14 shown
Timely Recovery After Subclinical Heart FailureNCT06341101 · 2024-03-26
UNKNOWN
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and DyslipidemiaNCT04591808 · 2021-09-09
TERMINATED
Precision Treatment With Angiotensin Converting Enzyme InhibitorNCT05535595 · 2019-11-06
COMPLETED
ACES - ACE Inhibitors Combined With Exercise for Seniors With HypertensionNCT03295734 · 2018-05-29
COMPLETED
Influence of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese SubjectsNCT02777489 · 2016-02-18
TERMINATED
RAS Peptide Profiles in Patients With Arterial HypertensionNCT02449811 · 2015-04-01
COMPLETED
Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease PatientsNCT02085265 · 2014-03-01
TERMINATED
PREclinical Mutation CARriers From Families With DIlated Cardiomyopathy and ACE InhibitorsNCT01583114 · 2011-12-01
TERMINATED
Perindopril vs Ramipril for Persistence in MAU Reduction StudyNCT02729441 · 2010-04-01
COMPLETED
Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential HypertensionNCT00461903 · 2007-12-01
COMPLETED
S90652 in Paediatric HypertensionNCT00202592 · 2003-11-01
COMPLETED
S90652 in Paediatric HypertensionNCT00202553 · 2003-07-01
COMPLETED
Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.NCT03921736 · 2000-01-10
COMPLETED
Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure StudyNCT01089452
WITHDRAWN

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.